Replication of the Stockholm Adoption Study of Alcoholism. Confirmatory Cross-fostering Analysis
Overview
Authors
Affiliations
Background: Two forms of alcoholism with distinct clinical features and mode of inheritance were first distinguished in the Stockholm Adoption Study. This involved a large sample of children born in Stockholm, Sweden, who were adopted at an early age and reared by nonrelatives. Type 1 alcoholism had adult onset and rapid progression of dependence without criminality, whereas type 2 had teenage onset of recurrent social and legal problems from alcohol abuse.
Methods: A replication study was carried out with 577 men and 660 women born in Gothenburg, Sweden, and adopted at an early age/by nonrelatives. The genetic and environmental backgrounds of the adoptees were classified by the exact procedures calibrated by discriminant analysis in the original study.
Results: Both type 2 and severe type 1 alcoholism were confirmed as independently heritable forms of alcoholism in male adoptees. The lifetime risk of severe alcoholism was increased 4-fold in adopted men with both genetic and environmental risk factors characteristic of type 1 alcoholism compared with the others (11.4% vs 3.0%). Neither genetic nor environmental risk factors for type 1 alcoholism by themselves were sufficient to cause alcoholism. In contrast, the risk of type 2 alcoholism was increased 6-fold in adopted sons with a type 2 genetic background compared with others; regardless of their postnatal environment (10.7% vs 2.0%). The sons with a type 2 genetic background in the replication sample had no excess of type 1 alcoholism, and vice versa. There was no increased risk of mild abuse in adopted men regardless of their genetic or environmental background.
Conclusion: Type 1 and type 2 alcoholism are clinically distinct forms of alcoholism with causes that are independent but not mutually exclusive.
Takagi M, Rhodes S, Kim J, King M, Soukar S, Martin C Vaccines (Basel). 2024; 12(7).
PMID: 39066425 PMC: 11281502. DOI: 10.3390/vaccines12070787.
Gentry A, Alexander J, Ahangari M, Peterson R, Miles M, Bettinger J PLoS One. 2023; 18(4):e0283985.
PMID: 37098020 PMC: 10128939. DOI: 10.1371/journal.pone.0283985.
Minnig M, Blasio A, Ferragud A, Sami Y, Erhard E, Clark R Neuropharmacology. 2022; 212:109063.
PMID: 35460713 PMC: 10342914. DOI: 10.1016/j.neuropharm.2022.109063.
A systems omics-based approach to decode substance use disorders and neuroadaptations.
Veerappa A, Pendyala G, Guda C Neurosci Biobehav Rev. 2021; 130:61-80.
PMID: 34411560 PMC: 8511293. DOI: 10.1016/j.neubiorev.2021.08.016.
Alcohol in Psoriasis-From Bench to Bedside.
Szentkereszty-Kovacs Z, Gaspar K, Szegedi A, Kemeny L, Kovacs D, Torocsik D Int J Mol Sci. 2021; 22(9).
PMID: 34067223 PMC: 8125812. DOI: 10.3390/ijms22094987.